BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 10499916)

  • 21. NK cell mediated recognition of HLA class Ib molecules: role of CD94/NKG2 receptors.
    Navarro F; Llano M; García P; López-Botet M
    J Reprod Immunol; 1999 Jul; 43(2):167-73. PubMed ID: 10479052
    [No Abstract]   [Full Text] [Related]  

  • 22. Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma.
    Vetter CS; Straten PT; Terheyden P; Zeuthen J; Bröcker EB; Becker JC
    J Invest Dermatol; 2000 May; 114(5):941-7. PubMed ID: 10771475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor.
    Ponte M; Cantoni C; Biassoni R; Tradori-Cappai A; Bentivoglio G; Vitale C; Bertone S; Moretta A; Moretta L; Mingari MC
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5674-9. PubMed ID: 10318943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene.
    Cantoni C; Biassoni R; Pende D; Sivori S; Accame L; Pareti L; Semenzato G; Moretta L; Moretta A; Bottino C
    Eur J Immunol; 1998 Jan; 28(1):327-38. PubMed ID: 9485212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes.
    Arlettaz L; Villard J; de Rham C; Degermann S; Chapuis B; Huard B; Roosnek E
    Eur J Immunol; 2004 Dec; 34(12):3456-64. PubMed ID: 15517612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular and functional characterization of NKG2D, NKp80, and NKG2C triggering NK cell receptors in rhesus and cynomolgus macaques: monitoring of NK cell function during simian HIV infection.
    Biassoni R; Fogli M; Cantoni C; Costa P; Conte R; Koopman G; Cafaro A; Ensoli B; Moretta A; Moretta L; De Maria A
    J Immunol; 2005 May; 174(9):5695-705. PubMed ID: 15843571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of CD94/NKG2 in innate and adaptive immunity.
    Gunturi A; Berg RE; Forman J
    Immunol Res; 2004; 30(1):29-34. PubMed ID: 15258309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD69-triggered ERK activation and functions are negatively regulated by CD94 / NKG2-A inhibitory receptor.
    Zingoni A; Palmieri G; Morrone S; Carretero M; Lopez-Botel M; Piccoli M; Frati L; Santoni A
    Eur J Immunol; 2000 Feb; 30(2):644-51. PubMed ID: 10671222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E.
    Braud VM; McMichael AJ
    Curr Top Microbiol Immunol; 1999; 244():85-95. PubMed ID: 10453651
    [No Abstract]   [Full Text] [Related]  

  • 30. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
    Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
    Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
    Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
    J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapy.
    Derre L; Corvaisier M; Pandolfino MC; Diez E; Jotereau F; Gervois N
    J Immunol; 2002 May; 168(10):4864-70. PubMed ID: 11994435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56.
    Tarazona R; DelaRosa O; Casado JG; Torre-Cisneros J; Villanueva JL; Galiani MD; Peña J; Solana R
    AIDS; 2002 Jan; 16(2):197-200. PubMed ID: 11807303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway.
    Zeddou M; Greimers R; de Valensart N; Nayjib B; Tasken K; Boniver J; Moutschen M; Rahmouni S
    Biochem Pharmacol; 2005 Sep; 70(5):714-24. PubMed ID: 15978547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
    Speiser DE; Valmori D; Rimoldi D; Pittet MJ; Liénard D; Cerundolo V; MacDonald HR; Cerottini JC; Romero P
    Eur J Immunol; 1999 Jun; 29(6):1990-9. PubMed ID: 10382762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p46, a novel natural killer cell-specific surface molecule that mediates cell activation.
    Sivori S; Vitale M; Morelli L; Sanseverino L; Augugliaro R; Bottino C; Moretta L; Moretta A
    J Exp Med; 1997 Oct; 186(7):1129-36. PubMed ID: 9314561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of natural killer cell receptors (CD94/NKG2A) on T cells by the stimulation of G-CSF-mobilized peripheral blood mononuclear cells with anti-CD3 monoclonal antibody and cytokines: a study in stem cell donors.
    Tanaka J; Toubai T; Miura Y; Tsutsumi Y; Kato N; Umehara S; Toyoshima N; Ohta S; Asaka M; Imamura M
    Transplant Proc; 2004 Oct; 36(8):2511-2. PubMed ID: 15561299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signal sequences stop killer cells.
    Long EO
    Nature; 1998 Feb; 391(6669):740-1, 743. PubMed ID: 9486638
    [No Abstract]   [Full Text] [Related]  

  • 39. Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation.
    Vance RE; Jamieson AM; Cado D; Raulet DH
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):868-73. PubMed ID: 11782535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor.
    Brooks AG; Posch PE; Scorzelli CJ; Borrego F; Coligan JE
    J Exp Med; 1997 Feb; 185(4):795-800. PubMed ID: 9034158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.